The supervisory board of German drug maker Schering has turned down a takeover bid by rival pharmaceuticals firm Merck even as Merck indicated it might be prepared to raise its offer. Following a special meeting of its supervisory board on Tuesday evening, Schering's managing director, Hubertus Erlen said the board had rejected Merck's takeover bid as inappropriate.
